Literature DB >> 57370

Letter: Baclofen in schizophrenia.

G M Simpson, M H Branchey, R K Shrivastava.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 57370     DOI： 10.1016/s0140-6736(76)92749-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Management of tardive dyskinesia: current update.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

2.  High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients.

Authors:  J N Nestoros; N P Nair; J R Pulman; G Schwartz; D Bloom
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

3.  Effect of baclofen on tardive dyskinesia.

Authors:  J Gerlach; T Rye; P Kristjansen
Journal:  Psychopharmacology (Berl)       Date:  1978-03-01       Impact factor: 4.530

4.  Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice.

Authors:  Marco Bortolato; Roberto Frau; Marco Orrù; A Paola Piras; Mauro Fà; Antonella Tuveri; Monica Puligheddu; Gian Luigi Gessa; M Paola Castelli; Giampaolo Mereu; Francesco Marrosu
Journal:  Psychopharmacology (Berl)       Date:  2007-06-29       Impact factor: 4.530

5.  GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.

Authors:  M J Gandal; J Sisti; K Klook; P I Ortinski; V Leitman; Y Liang; T Thieu; R Anderson; R C Pierce; G Jonak; R E Gur; G Carlson; S J Siegel
Journal:  Transl Psychiatry       Date:  2012-07-17       Impact factor: 6.222

6.  Clozapine Prolongs Cortical Silent Period in Patients with Treatment-Resistant Schizophrenia.

Authors:  Atsuhiro Miyazawa; Nobuhisa Kanahara; Yusuke Nakata; Satoshi Kodama; Hiroshi Kimura; Atsushi Kimura; Yasunori Oda; Hiroyuki Watanabe; Masaomi Iyo
Journal:  Psychopharmacol Bull       Date:  2021-03-16

Review 7.  Binding of clozapine to the GABAB receptor: clinical and structural insights.

Authors:  Pramod C Nair; Ross A McKinnon; John O Miners; Tarun Bastiampillai
Journal:  Mol Psychiatry       Date:  2020-03-13       Impact factor: 15.992
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.